EN
中文
EN
Who We Are
Newsroom
Innovation
Products
Investor Relations
Careers
Contact Us
Information Disclosure
Home
>
Investor Relations
>
Information Disclosure
H Share
VOLUNTARY ANNOUNCEMENT - THE CENTER FOR DRUG EVALUATION, NMPA GRANTED PRIORITY REVIEW STATUS TO NDA FOR TD5CP ADOLESCENT AND ADULT
Monthly Return of Equity Issuer on Movements in Securities
PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION AND THE RULES OF PROCEDURES
FIRST QUARTERLY REPORT FOR THE THREE MONTHS ENDED MARCH 31, 2026
Letter to Non-registered Shareholders - Reminder letter regarding the Arrangement of Electronic Dissemination of Corporate Communications and Reply Form
Letter to Registered Shareholders - Reminder letter regarding the Arrangement of Electronic Dissemination of Corporate Communications and Reply Form
2025 Environmental, Social and Governance (ESG) & Sustainability Report
2025 ANNUAL REPORT
NOTICE OF BOARD MEETING
INSIDE INFORMATION - NMPA OF CHINA GRANTS NDA APPROVAL TO DTCP INFANT
1
2
3
4
5
6
52
津公网安备12011602300399
